For the year ending 2025-12-31, FOLD has $949,870K in assets. $675,629K in debts. $214,010K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 214,010 | |||
| Investments in marketable securities | 79,526 | |||
| Accounts receivable, net | 115,307 | |||
| Inventories, net | 228,819 | |||
| Prepaid expenses and other current assets | 38,511 | |||
| Total current assets | 676,173 | |||
| Operating lease right-of-use assets, net | 21,138 | |||
| Property and equipment, less accumulated depreciation of 31,821 and 28,775 at december 31, 2025 and 2024, respectively | 27,108 | |||
| Intangible assets, less accumulated amortization of 9,085 and 5,802 at december 31, 2025 and 2024, respectively | 13,915 | |||
| Goodwill | 197,797 | |||
| Other non-current assets | 13,739 | |||
| Total assets | 949,870 | |||
| Accounts payable | 28,630 | |||
| Accrued expenses and other current liabilities | 200,457 | |||
| Operating lease liabilities | 8,741 | |||
| Total current liabilities | 237,828 | |||
| Long-term debt | 392,660 | |||
| Operating lease liabilities | 40,962 | |||
| Other non-current liabilities | 4,179 | |||
| Total liabilities | 675,629 | |||
| Common stock, 0.01 par value, 500,000,000 shares authorized, 310,853,963 and 299,041,653 shares issued and outstanding at december 31, 2025 and 2024, respectively | 3,037 | |||
| Common stock in treasury, at cost 7,390 shares as of december 31, 2025 | 71 | |||
| Additional paid-in capital | 3,014,456 | |||
| Foreign currency translation adjustment | 24,120 | |||
| Unrealized loss on available-for-sale securities | -11 | |||
| Warrants | 0 | |||
| Accumulated deficit | -2,767,290 | |||
| Total stockholders' equity | 274,241 | |||
| Total liabilities and stockholders' equity | 949,870 | |||
AMICUS THERAPEUTICS, INC. (FOLD)
AMICUS THERAPEUTICS, INC. (FOLD)